Live feed
Filing
SC 13G/A
SC 13G/A0001170316-20-000003·Ovid Therapeutics Inc.
Schedule 13G ownership disclosure
Ovid therapeutics, Inc.
Security class unavailable · CUSIP: 690469101
Event date: 2020-03-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,850,000
- Percent of class
- 5.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001170316-20-000003
- Form type
- SC 13G/A
- Filer
- Ovid Therapeutics Inc.
- CIK
- CIK 1636651
- Filed
- Mar 27, 2020
- Reporting period
- Mar 17, 2020
- Description
- Schedule 13G beneficial ownership